← Back to Search

Dietary Lentils for Hypertriglyceridemia

N/A
Waitlist Available
Led By Mary Miles, PhD
Research Sponsored by Montana State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial will investigate the impacts of pulse consumption, specifically green lentil consumption, on metabolic resilience and risk profiles for type 2 diabetes and cardiovascular disease.

Eligible Conditions
  • Hypertriglyceridemia
  • High Triglycerides
  • Inflammation

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Colony-Stimulating Factors
Fasting serum metabolites (untargeted)
Fasting serum triglycerides
+6 more
Secondary outcome measures
Blood Pressure
Body Composition
Body mass index
+3 more
Other outcome measures
Diet
Physical Activity

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: LentilExperimental Treatment1 Intervention
0.66 cups lentils
Group II: ControlPlacebo Group1 Intervention
0.0 cups lentils
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dietary Lentil
2020
N/A
~40

Find a Location

Who is running the clinical trial?

Montana State UniversityLead Sponsor
44 Previous Clinical Trials
1,043,806 Total Patients Enrolled
3 Trials studying Hypertriglyceridemia
77 Patients Enrolled for Hypertriglyceridemia
Mary Miles, PhDPrincipal InvestigatorMontana State University
1 Previous Clinical Trials
10 Total Patients Enrolled

Media Library

Dietary Lentil Clinical Trial Eligibility Overview. Trial Name: NCT04283448 — N/A
Hypertriglyceridemia Research Study Groups: Lentil, Control
Hypertriglyceridemia Clinical Trial 2023: Dietary Lentil Highlights & Side Effects. Trial Name: NCT04283448 — N/A
Dietary Lentil 2023 Treatment Timeline for Medical Study. Trial Name: NCT04283448 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the anticipated results of this investigation?

"The principal aim of this medical study, observed over the course of 12 weeks, is to measure the Postprandial Serum Inflammatory Cytokine Response (in pg/ml) after a High-fat Meal. Other secondary objectives include assessing Systolic and Diastolic Blood Pressure (mmHg), Body Mass Index in kg per m2 and also % body fat."

Answered by AI

Is enrollment open to participants for this research program?

"According to the public record on clinicaltrials.gov, this medical experiment is actively recruiting participants. The trial was first made available in May 2020 and has since been updated for current use as of late May 2022."

Answered by AI

How many people have agreed to participate in this investigation?

"Indeed, it appears that recruitment is still ongoing for this trial. The first posting was on May 22nd 2020 and the most recent update dates to May 27th 2022; 48 individuals are sought from a single location."

Answered by AI

Are elderly participants being accepted into this investigation?

"This medical trial is currently accepting participants who are over 18 years of age and below 70 years old."

Answered by AI

Does my profile qualify me to enter this experiment?

"This investigation is attempting to recruit 48 adults ranging from 18-70 years old that have a larger waist circumference and an elevated non-fasting serum triglyceride concentration (175 mg/dl). Notably, females must possess waists >35 inches while males need >40 inch circumferences."

Answered by AI
~8 spots leftby Apr 2025